The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

OxyNorm Dispersa 10 mg Orodispersible Tablets

Mundipharma Pharmaceuticals LimitedPA1688/006/008

Main Information

Trade NameOxyNorm Dispersa 10 mg Orodispersible Tablets
Dosage FormOrodispersible tablet
Licence HolderMundipharma Pharmaceuticals Limited
Licence NumberPA1688/006/008

Group Information

ATC CodeN02AA Natural opium alkaloids
N02AA05 oxycodone


License statusAuthorised
Licence Issued16/07/2010
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceThis product contains a substance listed in schedule 2 to the Misuse of Drugs Regulations 2017.
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version

Generics Information

Interchangeable List CodeIC0066-002-047
Interchangeable List DocumentPDF of Interchangeable List
« Back